Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children

Authors
Lee, Soon MinKim, Sung JinChen, JingSong, RokKim, Joon-HyungDevadiga, RaghavendraKim, Yun-Kyung
Issue Date
4-5월-2019
Publisher
TAYLOR & FRANCIS INC
Keywords
(5-10): DTaP-IPV; Post-marketing surveillance; Safety; Korea; Diphtheria; Tetanus; Pertussis; Poliomyelitis
Citation
HUMAN VACCINES & IMMUNOTHERAPEUTICS, v.15, no.5, pp.1145 - 1153
Indexed
SCIE
SCOPUS
Journal Title
HUMAN VACCINES & IMMUNOTHERAPEUTICS
Volume
15
Number
5
Start Page
1145
End Page
1153
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/65452
DOI
10.1080/21645515.2019.1572406
ISSN
2164-5515
Abstract
Infanrix-IPV (GSK, Belgium) is a diphtheria, tetanus, acellular pertussis, and inactivated poliovirus combination vaccine (DTaP-IPV) licensed in many countries including Korea. In accordance with Korean regulations, we conducted a post-marketing surveillance (PMS) to evaluate the safety of DTaP-IPV administered to Korean children in routine immunization schedules. Children aged <7 years receiving at least one dose of DTaP-IPV either as part of a primary (3-dose) vaccination series or as a subsequent booster were enrolled. Adverse events (AEs), adverse drug reactions (ADRs) and serious AEs (SAEs) were recorded after each dose during the 30-day post-vaccination follow-up period. Among a total of 639 children, 289 subjects (45.2%) experienced AEs, mostly (79.2%) assessed as being unlikely to be related to the vaccination. ADRs were reported in 13.0% of subjects. Fever was the most commonly reported expected AE (11.9% of subjects) and also the most commonly reported expected ADR (8.5% of subjects). No obvious association between AE incidence and vaccine dose sequence was apparent. An unexpected AE was seen in 32.9% of children, and unexpected ADRs were far less common (1.9%). Thirty-four SAEs were recorded in 26 subjects (4.1%), in two of whom a causal association with the vaccine could not be excluded, although both resolved quickly. Data from this PMS indicate that DTaP-IPV has an acceptable safety profile when given to Korean children in accordance with local prescribing recommendations in routine childhood immunization. ClinicalTrials.gov identifier: NCT01568060
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Kim, Yun Kyung photo

Kim, Yun Kyung
의과대학 (의학과)
Read more

Altmetrics

Total Views & Downloads

BROWSE